PDGFR
Members of the platelet-derived growth factor (PDGF) family stimulate the proliferation, survival and migration of mesenchymal cells and other cell types. The family consists of five isoforms, i.e. homodimers of A-, B-, C- and D-polypeptide chains and the AB-heterodimer, whichhave important functions during the embryonal development and in the control of tissue homeostasis in the adult. The PDGF isoforms act on their target cells via binding to structurally similar- and-tyrosine kinase receptors (PDGFR and PDGFR, respectively). Over-activity of PDGF signaling has been associated with the development of malignancies and other diseases involving excess cell proliferation. During embryonal development, PDGF isoforms are produced by epithelial and endothelial cells and act in a paracrine manner on neighboring mesenchymal cells, such as fibroblasts, pericytes and smooth muscle cells. There are a few tumor types in which mutations in the genes for PDGF isoforms or receptors drive tumor development.
Certain signaling molecules contain enzymatic activities, such as phospholipase C-(PLC), tyrosine kinases of the Src and Fer families, the GTP:ase activating protein (GAP) for Ras, and the SHP -2 tyrosine phosphatase. The autophosphorylated PDGF receptors also bind members of the STAT family which after phosphorylation by the receptors are activated and translocated into the nucleus, where they act as transcription factors. Other PDGF receptor binding molecules are adapt or molecules which form bridges to other signaling molecules; examples include the p85 regulatory subunit of phosphatidylinositol 3´-kinase (PI3-kinase) forming a complex with the p110 catalytic subunit, Grb2 forming a complex with the nucleotide exchange factor Sos1 which activates Ras and the downstream Erk1/2 MAPK-kinase pathway, as well as other adaptor molecules, including Nck, Shc,Crk and GAB2, which mediate interactions with many downstream signaling pathways. PDGF stimulation indirectly activates a number of additional signaling pathways, such as JNK, p38 and Erk5 MAP-kinase pathways and the small GTP:ases Rac, Rho and Cdc42. All these signaling pathways lead to stimulation of cell proliferation, survival and migration.
References
1.Heldin CH,et al. J Intern Med. 2018;283(1):16–44.
Certain signaling molecules contain enzymatic activities, such as phospholipase C-(PLC), tyrosine kinases of the Src and Fer families, the GTP:ase activating protein (GAP) for Ras, and the SHP -2 tyrosine phosphatase. The autophosphorylated PDGF receptors also bind members of the STAT family which after phosphorylation by the receptors are activated and translocated into the nucleus, where they act as transcription factors. Other PDGF receptor binding molecules are adapt or molecules which form bridges to other signaling molecules; examples include the p85 regulatory subunit of phosphatidylinositol 3´-kinase (PI3-kinase) forming a complex with the p110 catalytic subunit, Grb2 forming a complex with the nucleotide exchange factor Sos1 which activates Ras and the downstream Erk1/2 MAPK-kinase pathway, as well as other adaptor molecules, including Nck, Shc,Crk and GAB2, which mediate interactions with many downstream signaling pathways. PDGF stimulation indirectly activates a number of additional signaling pathways, such as JNK, p38 and Erk5 MAP-kinase pathways and the small GTP:ases Rac, Rho and Cdc42. All these signaling pathways lead to stimulation of cell proliferation, survival and migration.
References
1.Heldin CH,et al. J Intern Med. 2018;283(1):16–44.
Angiogenesis
PDGFR
-
Rinucumab
产品货号 : M36761
cas no: 1569263-06-4
Rinucumab (REGN 2176) 是一种单克隆抗体,是 PDGF 的抑制剂。Rinucumab (REGN 2176) 可用于新生血管性年龄相关性黄斑变性的研究。 -
Olaratumab
产品货号 : M36704
cas no: 1024603-93-7
Olaratumab(IMC-3G3; LY3012207) 是一种抗血小板衍生生长因子受体α (PDGFRα)的人单克隆 IgG1 抗体,具有抗肿瘤活性。 -
CT52923
产品货号 : M35387
cas no: 205256-55-9
CT52923 是一种选择性的血小板衍生生长因子受体 (PDGFR) 拮抗剂,具有口服活性。CT52923 也是一种 ATP 竞争性抑制剂。CT52923 可用于病理疾病的研究,包括动脉粥样硬化、肾小球肾炎、肝硬化、肺纤维化和癌症。 -
KN1022
产品货号 : M35326
cas no: 205255-11-4
KN1022 血小板衍生生长因子受体 (PDGFR) 磷酸化抑制剂,IC50 为 0.24 μM。 -
PDGFR Tyrosine Kinase Inhibitor III
产品货号 : M35325
cas no: 205254-94-0
PDGFR Tyrosine Kinase Inhibitor III (PDGF Receptor Tyrosine Kinase Inhibitor III)是一种多激酶抑制剂,可抑制 PDGFR、EGFR、FGFR、PKA 和 PKC 等。可用于研究肌萎缩侧索硬化症。